Analogous to AGs, the MAL erythromycin has also been used as a therapeutic TRID, in particular for treatment of familial adenomatous polyposis to repair PTC sequence variants in the APC (adenomatous polyposis coli) gene (Kariv et al, 2020). The gene discussed is APC; the disease is Familial adenomatous polyposis.